dPCR application in liquid biopsies: divide and conquer
- 30 December 2020
- journal article
- research article
- Published by Taylor & Francis Ltd in Expert Review of Molecular Diagnostics
- Vol. 21 (1), 3-15
- https://doi.org/10.1080/14737159.2021.1860759
Abstract
Precision medicine is already a reality in the field of oncology given that the selection and use of biomarker-driven therapies has clearly improved patient survival. Furthermore, a new, minimally invasive strategy termed ‘liquid biopsy’ (LB) has revolutionized the field by allowing comprehensive cancer genomic profiling through the analysis of circulating tumor DNA (ctDNA) released into the bloodstream. However, its detection requires extremely sensitive and efficient technologies. A powerful molecular tool based on the principle of ‘divide and conquer’ has emerged to solve this problem. Thus, digital PCR (dPCR) allows absolute and accurate quantification of target molecules. : In this review we will discuss the fundamentals of dPCR and the most common approaches used for partition of samples and quantification. The advantages and limitations of dPCR will be mentioned in the context of the field of LB in oncology. In our opinion, dPCR has proven to be one of the most sensitive methods available for LB analysis, even though some aspects such as its capacity of multiplexing and protocol standardization still require further improvements. Furthermore, the increasing sensitivities and lower costs of next generation sequencing (NGS) methods position dPCR as a confirmatory and complementary technique for NGS results which will likely prove very useful for treatment monitoring and assessing minimal residual disease.Keywords
Funding Information
- Spanish Health Institute Carlos III
This publication has 120 references indexed in Scilit:
- The Digital MIQE Guidelines: Minimum Information for Publication of Quantitative Digital PCR ExperimentsClinical Chemistry, 2013
- Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral BloodClinical Cancer Research, 2012
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion SequencingThe New England Journal of Medicine, 2012
- Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variationNucleic Acids Research, 2012
- High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy NumberAnalytical Chemistry, 2011
- Circulating DNA is a Useful Prognostic Factor in Patients with Advanced Non-small Cell Lung CancerJournal of Thoracic Oncology, 2011
- Development of Personalized Tumor Biomarkers Using Massively Parallel SequencingScience Translational Medicine, 2010
- Digital PCR provides sensitive and absolute calibration for high throughput sequencingBMC Genomics, 2009
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal CancerThe New England Journal of Medicine, 2008
- Mathematical Analysis of Copy Number Variation in a DNA Sample Using Digital PCR on a Nanofluidic DevicePLOS ONE, 2008